Experience with facilitated subcutaneous immunoglobulins in patients with primary antibody deficiency
2017
Abstract
Immunoglobulin supplementation therapy represents a corner stone in the treatment of patients with impaired of specific antibody production, who are prone to infectious diseases, mainly of bacterial origin. Specific treatment, the way of administration, dosage and substitution interval are highly individual.
The new way of administration is represented by hyaluronidase facilitated subcutaneous infusions. It is effective, safe and well-tolerated, equal to the others, having advantage of home-based subcutaneous therapy with a low number of application in a month.